The U.S. Food and Drug Administration allowed 23andMe to directly sell genetic testing those provides information on an individual’s genetic predisposition to certain medical disease or conditions in April this year. The approval become a milestone in the field of genetic testing. The development of genetic testing leads to an information explosion. Many people may question: "Is these information just for a one time use? Can the results be reused in the future?" GeneOnline interviewed Dr. Chris Tsai, founder of Bionet, to share how he assembled the core technology of Bionet and GGA. Bionet is a company aiming to provide everyone from youngers to seniors with a better life quality by integrating and reusing medical big data.